(Q38592514)

4 September 2017

Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review (English)

1 reference

4 September 2017

0 references

1 reference

Carolyn L Lekavich

1

1 reference

4 September 2017

Debra J Barksdale

series ordinal

2

1 reference

4 September 2017

Virginia Neelon

series ordinal

3

1 reference

4 September 2017

Jia-Rong Wu

series ordinal

4

1 reference

4 September 2017

24 September 2015

1 reference

4 September 2017

Heart Failure Reviews

1 reference

4 September 2017

20

1 reference

4 September 2017

6

1 reference

4 September 2017

643-653

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-015-9506-7

4 September 2017

0 references

cites work

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Ventricular-vascular interaction in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Reflections in hypertension: heart failure and hypertension: the diastolic dilemma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Diastolic failure: pathophysiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Invasive hemodynamic assessment in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Noninvasive single-beat determination of left ventricular end-systolic elastance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Diagnostic criteria for diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

The endotoxin-lipoprotein hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Lack of diastolic reserve in patients with heart failure and normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Spironolactone for heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Effects of exercise training for heart failure with preserved ejection fraction: a systematic review and meta-analysis of comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Factors associated with increased hospital utilization in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Prevalence, prospective risk markers, and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: the coronary artery risk development in young adults study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9506-7

Cardiovascular disease in the United States: an epidemiologic overview

21 January 2018

1 reference

12 December 2020

Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations

1 reference

12 December 2020

Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy. Systolic versus diastolic determinants

1 reference

12 December 2020

Factor Structure and Reliability of the Malay Version of the Perceived Stress Scale among Malaysian Medical Students

1 reference

12 December 2020

Racial differences in the outcomes of patients with diastolic heart failure

1 reference

12 December 2020

Risk factors for hypertension in a national cohort study

1 reference

12 December 2020

HFpEF: cardiovascular abnormalities not just comorbidities

1 reference

12 December 2020

Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study

1 reference

12 December 2020

AT1 and AT2 angiotensin receptor gene expression in human heart failure

1 reference

12 December 2020

Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)

1 reference

12 December 2020

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008

1 reference

12 December 2020

Sacubitril/Valsartan (Entresto) for Heart Failure

1 reference

12 December 2020

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

12 December 2020

Defining diastolic heart failure: a call for standardized diagnostic criteria

1 reference

12 December 2020

The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure

1 reference

12 December 2020

How to diagnose diastolic heart failure

1 reference

12 December 2020

The complex relationship of race to outcomes in heart failure with preserved ejection fraction

1 reference

12 December 2020

Heart failure with preserved ejection fraction

1 reference

12 December 2020

Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency

1 reference

12 December 2020

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response

1 reference

12 December 2020

The Ventricular-Arterial Coupling: From Basic Pathophysiology to Clinical Application in the Echocardiography Laboratory

1 reference

12 December 2020

Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction

1 reference

12 December 2020

10.1007/S10741-015-9506-7

Identifiers

DOI

1 reference

4 September 2017

1 reference